Yan, Huimin
Duan, Xin
Pan, Hua
Akk, Antonina
Sandell, Linda J.
Wickline, Samuel A.
Rai, Muhammad Farooq http://orcid.org/0000-0003-4826-4331
Pham, Christine T. N. http://orcid.org/0000-0003-1127-3699
Funding for this research was provided by:
National Heart and Lung Institute (HL073646)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR064837, AR067491)
Article History
Received: 29 May 2018
Accepted: 23 November 2018
First Online: 24 January 2019
Competing Interests
: SAW declares equity in Trasir Therapeutics, Inc. He is the author of pending patents for the peptide-siRNA technology (PCT/US2014/010212) that are assigned to Washington University (St Louis). LJS is Editor-in-Chief, Journal of Orthopaedic Research. CTNP serves as Editorial Member of the journal Precision Nanomedicine and on a NIH study section. HY, XD, HP, AA, MFR declare no competing interests.